https://pro.chooseyourselffinancial.com/p/PLA_alphabrainalert_0919/EPLAW4CB/?a=13&o=177827&s=208715&u=164704&l=3164288&r=MC2&vid=QpDzla&g=0&h=true Curious if anyone has tested this?
Today we have the uncertain pleasure of checking out a teaser pitch from James Altucher, who one of our readers referred to as the “white Don King of the stock gurus” — he’s peddling subscriptions to Altucher’s Investment Network (that’s his “entry level” letter, $79/year), and the bait he dangles out is his “special report” […]
Monthly entry-level newsletter with weekly updates… website says that “James and his inner circle will reveal their most explosive secrets about how to build wealth quickly and safely. They’ll share tips for navigating Wall Street, personal finance strategies, and tricks to boosting retirement income.”
I’m a little sad not to be in Omaha this weekend for the Berkshire meeting, but I’ll be watching some of the Q&A tomorrow to see how Warren and Charlie are looking and try to get some little nuggets of wisdom from them. The biggest news lately from Berkshire Hathaway (BRK-B) is that they’re at […]
Any thoughts on the Miracle cure that uses a Swiss Army Knife touted by Altucher ?
Gobble Gobble! It’s that time again! Stock Gumshoe is mostly closed down for the holiday week, but we do have to continue our annual tradition of calling out our “Turkey of the Year” … so take a pause from that turkey brining and join us, won’t you? What is this tradition, you ask? Every year, […]
James Altucher gives me a headache, but I guess that’s part of his brand as he uses his ‘wild and crazy entrepreneur who eschews convention but hobnobs with insiders’ image to sell his newsletters and books — for a while I felt like I was seeing his bobbing, wild-haired head in my dreams, trying to […]
Microcap and “penny stock” focused monthly newsletter from James Altucher. Aims to identify hot microcaps each month using his “extensive insider network.”
James Altucher took a little break from his self-chosen role as “most overmarketed cryptocurrency pundit on earth” to promote his publisher’s Microcap X Advisory recently, talking up the possibility that a particular little biotech stock could surge 54,000% because of expected FDA approval on February 17. So… let’s dig into it, shall we? The ad […]
Monthly stock-picking service that looks for “small value stocks.”
OK, so this one’s a bit tricky. And not just because the clues are a bit limited. Don’t worry, we’ll still find an answer for you … but a caveat or two first … Frank Curzio edits Phase 1 Investor, which is Stansberry’s “big ticket” newsletter that typically covers small tech, biotech and natural resources […]